StockMacro
Company, fund or insider

Help

Menu

Penumbra

$319.12 -2.8% in 6 monthsMarket cap $12.6B

PEN on XNYS, Health Care, Penumbra, Inc., job postings

Measures activity, not value. Not investment advice.

Revenue rose 17% to $1.6B over 12 months, but net income slipped 4.3%.

  • BadShort interest 6.1% of shares, up 6.2% from two weeks earlier
  • GoodLatest quarter revenue rose 16% to $410.1M

Written by AI from the data on this page, 21 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.

Industry
Surgical & medical instruments & apparatus (Health Care)
Employees
4,700
Website
penumbrainc.com
Listed
NYSE, US
Last results
29 Oct 2026
Next results
expected around 14 Jan 2027 (an estimate: a year ago it reported on 15 Jan 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $410.1M, net income $42.3M.
Quarter to 31 Dec 2021: revenue $204.0M, net income -$24.6MQuarter to 31 Dec 2021: revenue $204.0M, net income -$24.6MQuarter to 31 Mar 2022: revenue $203.9M, net income $79KQuarter to 31 Mar 2022: revenue $203.9M, net income $79KQuarter to 30 Jun 2022: revenue $208.3M, net income -$3.7MQuarter to 30 Jun 2022: revenue $208.3M, net income -$3.7MQuarter to 30 Sep 2022: revenue $213.7M, net income -$2.3MQuarter to 30 Sep 2022: revenue $213.7M, net income -$2.3MQuarter to 31 Dec 2022: revenue $221.2M, net income $3.9MQuarter to 31 Dec 2022: revenue $221.2M, net income $3.9MQuarter to 31 Mar 2023: revenue $241.4M, net income $8.6MQuarter to 31 Mar 2023: revenue $241.4M, net income $8.6MQuarter to 30 Jun 2023: revenue $261.5M, net income $19.0MQuarter to 30 Jun 2023: revenue $261.5M, net income $19.0MQuarter to 30 Sep 2023: revenue $270.9M, net income $9.2MQuarter to 30 Sep 2023: revenue $270.9M, net income $9.2MQuarter to 31 Dec 2023: revenue $284.7M, net income $54.2MQuarter to 31 Dec 2023: revenue $284.7M, net income $54.2MQuarter to 31 Mar 2024: revenue $278.7M, net income $11.0MQuarter to 31 Mar 2024: revenue $278.7M, net income $11.0MQuarter to 30 Jun 2024: revenue $299.4M, net income -$60.2MQuarter to 30 Jun 2024: revenue $299.4M, net income -$60.2MQuarter to 30 Sep 2024: revenue $301.0M, net income $29.5MQuarter to 30 Sep 2024: revenue $301.0M, net income $29.5MQuarter to 31 Dec 2024: revenue –, net income $33.7MQuarter to 31 Mar 2025: revenue $324.1M, net income $39.2MQuarter to 31 Mar 2025: revenue $324.1M, net income $39.2MQuarter to 30 Jun 2025: revenue $339.5M, net income $45.3MQuarter to 30 Jun 2025: revenue $339.5M, net income $45.3MQuarter to 30 Sep 2025: revenue $354.7M, net income $45.9MQuarter to 30 Sep 2025: revenue $354.7M, net income $45.9MQuarter to 31 Dec 2025: revenue –, net income $47.3MQuarter to 31 Mar 2026: revenue $374.8M, net income $32.6MQuarter to 31 Mar 2026: revenue $374.8M, net income $32.6MQuarter to 30 Jun 2026: revenue $390.0M, net income $34.8MQuarter to 30 Jun 2026: revenue $390.0M, net income $34.8MQuarter to 30 Sep 2026: revenue $410.1M, net income $42.3MQuarter to 30 Sep 2026: revenue $410.1M, net income $42.3M
31 Dec 2021RevenueNet incomeNet losstallest bar $410.1M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$410.1M$42.3M
30 Jun 2026$390.0M$34.8M
31 Mar 2026$374.8M$32.6M
31 Dec 2025–$47.3M
30 Sep 2025$354.7M$45.9M
30 Jun 2025$339.5M$45.3M
31 Mar 2025$324.1M$39.2M
31 Dec 2024–$33.7M
30 Sep 2024$301.0M$29.5M
30 Jun 2024$299.4M-$60.2M
31 Mar 2024$278.7M$11.0M
31 Dec 2023$284.7M$54.2M
30 Sep 2023$270.9M$9.2M
30 Jun 2023$261.5M$19.0M
31 Mar 2023$241.4M$8.6M
31 Dec 2022$221.2M$3.9M
30 Sep 2022$213.7M-$2.3M
30 Jun 2022$208.3M-$3.7M
31 Mar 2022$203.9M$79K
31 Dec 2021$204.0M-$24.6M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $1.6B $1.3B
Revenue growthRevenue of the last 12 months compared with the 12 months before. +17% +13%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $157.0M $164.0M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $3.97 $4.19
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 68.0% 66.8% 60.5%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 12.1% 13.0% -8.3%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 10.1% 12.3% -10.1%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 10.7% -26.3%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $200.3M $152.6M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $673.6M $470.3M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. – –
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). – –
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. – 0.31
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $40.18
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 80.1 28.0
P/SPrice to sales: market cap divided by revenue of the last 12 months. 8.1 2.3
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 2.5
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 7.9 2.8

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
PenumbraPEN (this company) $12.6B80.18.1+17%10.1%
Baxter InternationalBAX $13.1Bloss1.1+6.0%-6.0%
GlaukosGKOS $14.0Bloss20.3+47%-24.6%
SolventumSOLV $14.3B91.91.8-2.8%1.9%
InsuletPODD $9.2B21.52.9+26%13.4%
Globus MedicalGMED $8.9B16.12.9+13%17.8%

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+16%

$410.1M vs $354.7M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

-7.0%

$15.1M vs $16.2M (quarter ended 30 Sep 2026)

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

-2.7%

427 13F filers vs 439

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

88%

34.7M shares held by 13F filers (30 Sep 2026) of 39.4M outstanding (14 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

6.1%

2.4M shares sold short (30 Oct 2026) of 39.4M outstanding (14 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

5.3

2.4M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+6.2%

2.3M shares sold short in the report before, 2.4M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

45%

45% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 51%

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

+67%

50 vs 30 applications

News Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

22

22 articles in the last 7 days; its usual week has 2.5 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

8.8×

22 articles in the last 7 days; its usual week has 2.5.

Price $319.12 on 20 Nov 2026, +14% over 12 months (12-month range $279.79 to $359.40)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $5.9M in the last 12 months (the 12 months before: -$102.2M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 50 published in the last 12 months, +67% on the 12 months before.
Revenue per quarter. Revenue $410.1M in the latest quarter, +16% on a year earlier.
Capital spending per quarter. Capital spending $15.1M in the latest quarter, -7.0% on a year earlier.
Institutional holders (13F filers). 427 13F filers reported holding it in the latest 13F quarter, +6.7% on a year earlier.
Federal obligations. Federal obligations: $0 published in the last 12 months, -100% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
19 May 2026Sharp changeMany funds opening a new position: many funds opening a new position, 116 vs usual 53.50 (2026-03-31); 1.4x the same period a year earlier
14 Apr 2026Sharp changeShort interest spike: short interest spike, 2.4M vs usual 1.7M (2026-03-31); 1.6x the same period a year earlier
26 Feb 2026Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 18.4M vs usual 5.6M (2025-12-31); 3.4x the same period a year earlier
6 Nov 2025Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 16.2M vs usual 5.4M (2025-09-30); 3.0x the same period a year earlier
27 Aug 20258-K and other filingsDirector or officer change
27 Aug 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
31 Jul 2025Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 15.6M vs usual 5.0M (2025-06-30); 3.4x the same period a year earlier
15 May 2025Sharp changeMany funds opening a new position: many funds opening a new position, 80 vs usual 46.50 (2025-03-31); 2.0x the same period a year earlier
29 Apr 2025Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 13.5M vs usual 4.4M (2025-03-31); 2.3x the same period a year earlier
21 Feb 20258-K and other filingsDirector or officer change
21 Feb 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
21 Mar 20248-K and other filingsChanged its auditor
27 Feb 2024Sharp changeQuarterly revenue change: quarterly revenue change, 284.7M vs usual 217.4M (2023-12-31); 1.3x the same period a year earlier
15 Aug 2023Sharp changeMany funds opening a new position: many funds opening a new position, 79 vs usual 38.50 (2023-06-30); 2.5x the same period a year earlier
17 Jan 2023Sharp changeShort interest spike: short interest spike, 3.8M vs usual 2.0M (2022-12-30); 2.0x the same period a year earlier
3 Jan 2023Sharp changeShort interest spike: short interest spike, 3.6M vs usual 1.8M (2022-12-15); 1.9x the same period a year earlier
13 Dec 2022Sharp changeShort interest spike: short interest spike, 3.3M vs usual 1.8M (2022-11-30); 2.1x the same period a year earlier
29 Nov 2022Sharp changeShort interest spike: short interest spike, 3.1M vs usual 1.8M (2022-11-15); 2.0x the same period a year earlier
15 Nov 2022Sharp changeShort interest spike: short interest spike, 2.8M vs usual 1.8M (2022-10-31); 1.6x the same period a year earlier
8 Apr 20228-K and other filingsDirector or officer change
8 Apr 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Dec 2021: -$4.0M published
Month from 1 Jan 2022: -$4.8M published
Month from 1 Mar 2022: -$338K published
Month from 1 Apr 2022: -$344K published
Month from 1 Jul 2022: -$46K published
Month from 1 Aug 2022: -$310K published
Month from 1 Sep 2022: -$1.0M published
Month from 1 Oct 2022: -$335K published
Month from 1 Nov 2022: -$292K published
Month from 1 Dec 2022: -$315K published
Month from 1 Jan 2023: -$5.0M published
Month from 1 Feb 2023: -$1.4M published
Month from 1 Mar 2023: -$1.9M published
Month from 1 Apr 2023: -$1.8M published
Month from 1 May 2023: -$5.0M published
Month from 1 Jun 2023: -$3.4M published
Month from 1 Jul 2023: -$3.4M published
Month from 1 Aug 2023: -$2.7M published
Month from 1 Sep 2023: -$3.3M published
Month from 1 Oct 2023: -$2.3M published
Month from 1 Nov 2023: -$128K published
Month from 1 Dec 2023: -$170K published
Month from 1 Jan 2024: -$62K published
Month from 1 Mar 2024: -$2.2M published
Month from 1 Apr 2024: -$168K published
Month from 1 May 2024: -$3.1M published
Month from 1 Jun 2024: -$113K published
Month from 1 Jul 2024: -$3.2M published
Month from 1 Aug 2024: -$6.2M published
Month from 1 Sep 2024: -$3.2M published
Month from 1 Oct 2024: -$3.2M published
Month from 1 Nov 2024: -$3.7M published
Month from 1 Dec 2024: -$4.4M published
Month from 1 Jan 2025: -$81K published
Month from 1 Mar 2025: -$31.9M published
Month from 1 Apr 2025: -$13.2M published
Month from 1 May 2025: -$15.0M published
Month from 1 Jun 2025: -$8.2M published
Month from 1 Jul 2025: -$7.8M published
Month from 1 Aug 2025: -$11.6M published
Month from 1 Sep 2025: -$4.5M published
Month from 1 Oct 2025: -$243K published
Month from 1 Nov 2025: -$5.2M published
Month from 1 Dec 2025: -$4.9M published
Month from 1 Jan 2026: -$116K published
Month from 1 Mar 2026: -$832K published
Month from 1 Apr 2026: -$33K published
H-1B/E-3 applications certified
Quarter from 1 Jan 2022: 7 published
Quarter from 1 Apr 2022: 23 published
Quarter from 1 Jul 2022: 9 published
Quarter from 1 Oct 2022: 4 published
Quarter from 1 Jan 2023: 1 published
Quarter from 1 Apr 2023: 24 published
Quarter from 1 Jul 2023: 9 published
Quarter from 1 Oct 2023: 9 published
Quarter from 1 Jan 2024: 4 published
Quarter from 1 Apr 2024: 20 published
Quarter from 1 Jul 2024: 10 published
Quarter from 1 Oct 2024: 4 published
Quarter from 1 Jan 2025: 3 published
Quarter from 1 Apr 2025: 6 published
Quarter from 1 Jul 2025: 18 published
Quarter from 1 Oct 2025: 3 published
Quarter from 1 Jan 2026: 9 published
Quarter from 1 Apr 2026: 12 published
Quarter from 1 Jul 2026: 22 published
Quarter from 1 Oct 2026: 7 published
Revenue per quarter
Quarter ended 31 Dec 2021: $204.0M, +22% on a year earlier; public on 23 Feb 2022
Quarter ended 31 Mar 2022: $203.9M, +21% on a year earlier; public on 4 May 2022
Quarter ended 30 Jun 2022: $208.3M, +13% on a year earlier; public on 6 Aug 2022
Quarter ended 30 Sep 2022: $213.7M, +12% on a year earlier; public on 4 Nov 2022
Quarter ended 31 Dec 2022: $221.2M, +8.4% on a year earlier; public on 24 Feb 2023
Quarter ended 31 Mar 2023: $241.4M, +18% on a year earlier; public on 3 May 2023
Quarter ended 30 Jun 2023: $261.5M, +26% on a year earlier; public on 2 Aug 2023
Quarter ended 30 Sep 2023: $270.9M, +27% on a year earlier; public on 3 Nov 2023
Quarter ended 31 Dec 2023: $284.7M, +29% on a year earlier; public on 23 Feb 2024
Quarter ended 31 Mar 2024: $278.7M, +15% on a year earlier; public on 8 May 2024
Quarter ended 30 Jun 2024: $299.4M, +14% on a year earlier; public on 31 Jul 2024
Quarter ended 30 Sep 2024: $301.0M, +11% on a year earlier; public on 31 Oct 2024
Quarter ended 31 Mar 2025: $324.1M, +16% on a year earlier; public on 24 Apr 2025
Quarter ended 30 Jun 2025: $339.5M, +13% on a year earlier; public on 30 Jul 2025
Quarter ended 30 Sep 2025: $354.7M, +18% on a year earlier; public on 6 Nov 2025
Quarter ended 31 Mar 2026: $374.8M, +16% on a year earlier; public on 7 May 2026
Quarter ended 30 Jun 2026: $390.0M, +15% on a year earlier; public on 31 Jul 2026
Quarter ended 30 Sep 2026: $410.1M, +16% on a year earlier; public on 30 Oct 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $8.1M, +116% on a year earlier; public on 23 Feb 2022
Quarter ended 31 Mar 2022: $5.0M, +24% on a year earlier; public on 4 May 2022
Quarter ended 30 Jun 2022: $4.4M, +34% on a year earlier; public on 6 Aug 2022
Quarter ended 30 Sep 2022: $6.3M, +9.4% on a year earlier; public on 4 Nov 2022
Quarter ended 31 Dec 2022: $3.6M, -56% on a year earlier; public on 24 Feb 2023
Quarter ended 31 Mar 2023: $3.9M, -21% on a year earlier; public on 3 May 2023
Quarter ended 30 Jun 2023: $4.3M, -2.0% on a year earlier; public on 2 Aug 2023
Quarter ended 30 Sep 2023: $3.3M, -48% on a year earlier; public on 3 Nov 2023
Quarter ended 31 Dec 2023: $3.6M, +2.3% on a year earlier; public on 23 Feb 2024
Quarter ended 31 Mar 2024: $5.8M, +50% on a year earlier; public on 8 May 2024
Quarter ended 30 Jun 2024: $4.5M, +4.5% on a year earlier; public on 31 Jul 2024
Quarter ended 30 Sep 2024: $5.5M, +64% on a year earlier; public on 31 Oct 2024
Quarter ended 31 Dec 2024: $5.4M, +47% on a year earlier; public on 19 Feb 2025
Quarter ended 31 Mar 2025: $13.5M, +131% on a year earlier; public on 24 Apr 2025
Quarter ended 30 Jun 2025: $15.6M, +243% on a year earlier; public on 30 Jul 2025
Quarter ended 30 Sep 2025: $16.2M, +198% on a year earlier; public on 6 Nov 2025
Quarter ended 31 Dec 2025: $18.4M, +243% on a year earlier; public on 26 Feb 2026
Quarter ended 31 Mar 2026: $13.7M, +1.5% on a year earlier; public on 7 May 2026
Quarter ended 30 Jun 2026: $13.5M, -13% on a year earlier; public on 31 Jul 2026
Quarter ended 30 Sep 2026: $15.1M, -7.0% on a year earlier; public on 30 Oct 2026
Institutional holders (13F filers)
31 Dec 2021 report: 252; public on 14 Feb 2022
31 Mar 2022 report: 268; public on 16 May 2022
30 Jun 2022 report: 242; public on 15 Aug 2022
30 Sep 2022 report: 239; public on 14 Nov 2022
31 Dec 2022 report: 263; public on 14 Feb 2023
31 Mar 2023 report: 291; public on 15 May 2023
30 Jun 2023 report: 340; public on 14 Aug 2023
30 Sep 2023 report: 286; public on 14 Nov 2023
31 Dec 2023 report: 317; public on 14 Feb 2024
31 Mar 2024 report: 325; public on 15 May 2024
30 Jun 2024 report: 325; public on 14 Aug 2024
30 Sep 2024 report: 313; public on 14 Nov 2024
31 Dec 2024 report: 364; public on 14 Feb 2025
31 Mar 2025 report: 405; public on 15 May 2025
30 Jun 2025 report: 430; public on 14 Aug 2025
30 Sep 2025 report: 400; public on 14 Nov 2025
31 Dec 2025 report: 424; public on 17 Feb 2026
31 Mar 2026 report: 475; public on 15 May 2026
30 Jun 2026 report: 439; public on 14 Aug 2026
30 Sep 2026 report: 427; public on 16 Nov 2026
Federal obligations
Month from 1 Nov 2021: $14K published
Month from 1 Dec 2021: $21K published
Month from 1 Feb 2022: $71K published
Month from 1 Mar 2022: $27K published
Month from 1 Apr 2022: $29K published
Month from 1 May 2022: $35K published
Month from 1 Jun 2022: $15K published
Month from 1 Jul 2022: $61K published
Month from 1 Aug 2022: $132K published
Month from 1 Oct 2022: $14K published
Month from 1 Nov 2022: $33K published
Month from 1 Dec 2022: $13K published
Month from 1 Jan 2023: $48K published
Month from 1 Feb 2023: $21K published
Month from 1 Mar 2023: $18K published
Month from 1 Apr 2023: $86K published
Month from 1 Jun 2023: $135K published
Month from 1 Jul 2023: $27K published
Month from 1 Aug 2023: $104K published
Month from 1 Sep 2023: $26K published
Month from 1 Oct 2023: $35K published
Month from 1 Nov 2023: $76K published
Month from 1 Dec 2023: $132K published
Month from 1 Jan 2024: $12K published
Month from 1 Mar 2024: $42K published
Month from 1 Apr 2024: $58K published
Month from 1 May 2024: $29K published
Month from 1 Jun 2024: $15K published
Month from 1 Jul 2024: $67K published
Month from 1 Aug 2024: $21K published
Month from 1 Sep 2024: $66K published
Month from 1 Oct 2024: $64K published
Month from 1 Dec 2024: $13K published
Month from 1 Feb 2025: $25K published
Month from 1 Mar 2025: $97K published
Month from 1 Apr 2025: $12K published
Month from 1 May 2025: $11K published
Month from 1 Jul 2026: $0 published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is revenue, quarter at $410.1M (30 Sep 2026), 1.2× its normal quarter; higher than 100% of its own history.
  • Insider net buying (open market): Insiders sold a net $5.9M in the last 12 months (the 12 months before: -$102.2M).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 50 published in the last 12 months, +67% on the 12 months before.
  • Revenue per quarter: Revenue $410.1M in the latest quarter, +16% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

No trades in the last 90 days; the latest was filed 6 Apr 2026. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
6 Apr 2026Harpreet GrewalDirectorSellplanned in advance (10b5-1)100$328.22$33KForm 4
4 Mar 2026Maggie YuenChief Financial OfficerSellplanned in advance (10b5-1)2,432$342.30$832KForm 4
8 Jan 2026Harpreet GrewalDirectorSellplanned in advance (10b5-1)186$312.64$58KForm 4
6 Jan 2026Thomas WilderDirectorSellplanned in advance (10b5-1)186$310.72$58KForm 4
15 Dec 2025Arani BoseDirectorSellplanned in advance (10b5-1)15,000$308.82$4.6MForm 4
9 Dec 2025Johanna RobertsEVP, Gen. Counsel & SecretarySellplanned in advance (10b5-1)300$300.13$90KForm 4
3 Dec 2025Johanna RobertsEVP, Gen. Counsel & SecretarySellplanned in advance (10b5-1)600$294.94$177KForm 4
3 Dec 2025Harpreet GrewalDirectorSellplanned in advance (10b5-1)100$292.98$29KForm 4

427 institutions reported shares at the end of Q3 2026, 88% of the shares outstanding; 44 opened a position, 57 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.4.3M10.9%$1.4B+2,651+0.1%
HBK Investments L P1.9M4.77%$599.0M+43K+2.4%
Vanguard Capital Management LLC1.7M4.32%$542.6M-5,499-0.3%
Vanguard Portfolio Management LLC1.6M4.15%$520.3M-33K-2.0%
UBS Group AG1.5M3.72%$466.9M+763K+108%
JPMorgan Chase & Co1.4M3.64%$458.7M+365K+34%
ExodusPoint Capital Management, LP1.4M3.61%$453.5M+334K+31%
Arrowstreet Capital, Limited Partnership1.4M3.51%$440.1M+548K+66%
State Street Corp1.2M3.14%$393.5M-7,154-0.6%
Goldman Sachs Group Inc1.2M2.97%$372.4M+323K+38%

Company events

All 20 company events

In 12 months: 1 major agreement. Results releases and routine reports are left out.

FiledWhat happenedSource
15 Jan 2026Signed a major agreement8-K
27 Aug 2025Director or officer change8-K
21 Feb 2025Director or officer change8-K
21 Mar 2024Changed its auditor8-K
8 Apr 2022Director or officer change8-K
7 Oct 2021Completed an acquisition or asset saleSame filing: sold shares privately8-K
1 Jun 2020Signed a major agreement8-K
12 May 2020Director or officer change8-K

Reported lobbying spend: $90K in Q4 2016. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
1 Jul 2017EndedPenumbra, Inc.its own lobbyistsNot statedFiling
27 Oct 2016NewPenumbra, Inc.its own lobbyistsReimbursement and stroke care.Health issues, Medicare/MedicaidFiling

The 5 newest of 162 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

15 May 2025confirmed

Confirmed across sources Institutional holdings and Filings + Financials

Penumbra (PEN): spent $13.5M on capital projects in the quarter ended 31 Mar 2025, 2.3× the same quarter last year, while it saw 80 13F filers open a new position in the quarter ended 31 Mar 2025, 2.0× the same quarter last year. Two unrelated kinds of activity within 16 days.

  • Financials: Quarterly capital spending jump, became public on 29 Apr 2025
  • Institutional holdings: Many funds opening a new position, became public on 15 May 2025
2023-03-31: $3.9M2023-06-30: $4.3M2023-09-30: $3.3M2023-12-31: $3.6M2024-03-31: $5.8M2024-06-30: $4.5M2024-09-30: $5.5M2024-12-31: $5.4M2025-03-31: $13.5M
The quarter ended 31 Mar 2025 against the 8 quarters before it. this quarterearliernormal: $4.4M
See the evidence (2 changes)

Financials: Quarterly capital spending jump became public on 29 Apr 2025

Penumbra spent $13.5M on capital projects in the quarter ended 31 Mar 2025, 2.3× the same quarter last year.

This period
$13.5M (the quarter ended 31 Mar 2025)
Normal quarter (median of 8 earlier)
$4.4M
Typical spread (median absolute deviation)
$863K
How far from its usual level
+7.1
Same quarter last year
$5.8M
History used
3,743 days
2023-03-31: $3.9M2023-06-30: $4.3M2023-09-30: $3.3M2023-12-31: $3.6M2024-03-31: $5.8M2024-06-30: $4.5M2024-09-30: $5.5M2024-12-31: $5.4M2025-03-31: $13.5M
the quarter ended 31 Mar 20258 earlier quartersnormal: $4.4M

Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

Check it at the source: SEC EDGAR quarterly reports.

Institutional holdings: Many funds opening a new position became public on 15 May 2025

Penumbra saw 80 13F filers open a new position in the quarter ended 31 Mar 2025, 2.0× the same quarter last year.

This period
80 (the quarter ended 31 Mar 2025)
Normal quarter (median of 8 earlier)
46.5
Typical spread (median absolute deviation)
6
How far from its usual level
+3.8
Same quarter last year
41
History used
3,470 days
2023-03-31: 502023-06-30: 792023-09-30: 292023-12-31: 432024-03-31: 412024-06-30: 542024-09-30: 432024-12-31: 532025-03-31: 80
the quarter ended 31 Mar 20258 earlier quartersnormal: 46.5

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 15 May 2026Institutional holdings change

    saw 116 13F filers open a new position in the quarter ended 31 Mar 2026, 1.4× the same quarter last year.

    Same quarter last year: 80; its normal quarter is 53.5.

    See the evidence
    This period
    116 (the quarter ended 31 Mar 2026)
    Normal quarter (median of 8 earlier)
    53.5
    Typical spread (median absolute deviation)
    11
    How far from its usual level
    +3.8
    Same quarter last year
    80
    History used
    3,835 days
    2024-03-31: 412024-06-30: 542024-09-30: 432024-12-31: 532025-03-31: 802025-06-30: 752025-09-30: 462025-12-31: 652026-03-31: 116
    the quarter ended 31 Mar 20268 earlier quartersnormal: 53.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  2. 11 Apr 2026Short interest and volume change

    had 2.4M shares sold short in the 31 Mar 2026 report, 1.6× the same report last year.

    Same report last year: 1.5M; its normal report is 1.7M.

    See the evidence
    This period
    2.4M (the 31 Mar 2026 report)
    Normal report (median of 24 earlier)
    1.7M
    Typical spread (median absolute deviation)
    141K
    How far from its usual level
    +3.7
    Same report last year
    1.5M
    History used
    3,014 days
    2025-03-31: 1.5M2025-04-15: 1.6M2025-04-30: 1.5M2025-05-15: 1.5M2025-05-30: 1.3M2025-06-13: 1.5M2025-06-30: 1.9M2025-07-15: 1.8M2025-07-31: 1.5M2025-08-15: 1.6M2025-08-29: 1.8M2025-09-15: 2.0M2025-09-30: 1.6M2025-10-15: 1.7M2025-10-31: 1.8M2025-11-14: 1.7M2025-11-28: 1.5M2025-12-15: 1.6M2025-12-31: 1.7M2026-01-15: 1.7M2026-01-30: 1.6M2026-02-13: 1.9M2026-02-27: 1.9M2026-03-13: 2.1M2026-03-31: 2.4M
    the 31 Mar 2026 report24 earlier reportsnormal: 1.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  3. 26 Feb 2026Financials change

    spent $18.4M on capital projects in the quarter ended 31 Dec 2025, 3.4× the same quarter last year.

    Same quarter last year: $5.4M; its normal quarter is $5.6M.

    See the evidence
    This period
    $18.4M (the quarter ended 31 Dec 2025)
    Normal quarter (median of 8 earlier)
    $5.6M
    Typical spread (median absolute deviation)
    $1.5M
    How far from its usual level
    +5.6
    Same quarter last year
    $5.4M
    History used
    3,562 days
    2023-12-31: $3.6M2024-03-31: $5.8M2024-06-30: $4.5M2024-09-30: $5.5M2024-12-31: $5.4M2025-03-31: $13.5M2025-06-30: $15.6M2025-09-30: $16.2M2025-12-31: $18.4M
    the quarter ended 31 Dec 20258 earlier quartersnormal: $5.6M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  4. 6 Nov 2025Financials change

    spent $16.2M on capital projects in the quarter ended 30 Sep 2025, 3.0× the same quarter last year.

    Same quarter last year: $5.5M; its normal quarter is $5.4M.

    See the evidence
    This period
    $16.2M (the quarter ended 30 Sep 2025)
    Normal quarter (median of 8 earlier)
    $5.4M
    Typical spread (median absolute deviation)
    $1.3M
    How far from its usual level
    +5.5
    Same quarter last year
    $5.5M
    History used
    3,470 days
    2023-09-30: $3.3M2023-12-31: $3.6M2024-03-31: $5.8M2024-06-30: $4.5M2024-09-30: $5.5M2024-12-31: $5.4M2025-03-31: $13.5M2025-06-30: $15.6M2025-09-30: $16.2M
    the quarter ended 30 Sep 20258 earlier quartersnormal: $5.4M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  5. 27 Aug 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  6. 27 Aug 2025Filings record

    Director or officer change

  7. 31 Jul 2025Financials change

    spent $15.6M on capital projects in the quarter ended 30 Jun 2025, 3.4× the same quarter last year.

    Same quarter last year: $4.5M; its normal quarter is $5.0M.

    See the evidence
    This period
    $15.6M (the quarter ended 30 Jun 2025)
    Normal quarter (median of 8 earlier)
    $5.0M
    Typical spread (median absolute deviation)
    $741K
    How far from its usual level
    +9.7
    Same quarter last year
    $4.5M
    History used
    3,378 days
    2023-06-30: $4.3M2023-09-30: $3.3M2023-12-31: $3.6M2024-03-31: $5.8M2024-06-30: $4.5M2024-09-30: $5.5M2024-12-31: $5.4M2025-03-31: $13.5M2025-06-30: $15.6M
    the quarter ended 30 Jun 20258 earlier quartersnormal: $5.0M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  8. 15 May 2025several at once

    spent $13.5M on capital projects in the quarter ended 31 Mar 2025, 2.3× the same quarter last year, while it saw 80 13F filers open a new position in the quarter ended 31 Mar 2025, 2.0× the same quarter last year. Two unrelated kinds of activity within 16 days.

    See the evidence (2 changes)

    Financials: Quarterly capital spending jump became public on 29 Apr 2025

    Penumbra spent $13.5M on capital projects in the quarter ended 31 Mar 2025, 2.3× the same quarter last year.

    This period
    $13.5M (the quarter ended 31 Mar 2025)
    Normal quarter (median of 8 earlier)
    $4.4M
    Typical spread (median absolute deviation)
    $863K
    How far from its usual level
    +7.1
    Same quarter last year
    $5.8M
    History used
    3,743 days
    2023-03-31: $3.9M2023-06-30: $4.3M2023-09-30: $3.3M2023-12-31: $3.6M2024-03-31: $5.8M2024-06-30: $4.5M2024-09-30: $5.5M2024-12-31: $5.4M2025-03-31: $13.5M
    the quarter ended 31 Mar 20258 earlier quartersnormal: $4.4M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

    Institutional holdings: Many funds opening a new position became public on 15 May 2025

    Penumbra saw 80 13F filers open a new position in the quarter ended 31 Mar 2025, 2.0× the same quarter last year.

    This period
    80 (the quarter ended 31 Mar 2025)
    Normal quarter (median of 8 earlier)
    46.5
    Typical spread (median absolute deviation)
    6
    How far from its usual level
    +3.8
    Same quarter last year
    41
    History used
    3,470 days
    2023-03-31: 502023-06-30: 792023-09-30: 292023-12-31: 432024-03-31: 412024-06-30: 542024-09-30: 432024-12-31: 532025-03-31: 80
    the quarter ended 31 Mar 20258 earlier quartersnormal: 46.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  9. 15 May 2025Institutional holdings change

    saw 80 13F filers open a new position in the quarter ended 31 Mar 2025, 2.0× the same quarter last year.

    Same quarter last year: 41; its normal quarter is 46.5.

    See the evidence
    This period
    80 (the quarter ended 31 Mar 2025)
    Normal quarter (median of 8 earlier)
    46.5
    Typical spread (median absolute deviation)
    6
    How far from its usual level
    +3.8
    Same quarter last year
    41
    History used
    3,470 days
    2023-03-31: 502023-06-30: 792023-09-30: 292023-12-31: 432024-03-31: 412024-06-30: 542024-09-30: 432024-12-31: 532025-03-31: 80
    the quarter ended 31 Mar 20258 earlier quartersnormal: 46.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  10. 29 Apr 2025Financials change

    spent $13.5M on capital projects in the quarter ended 31 Mar 2025, 2.3× the same quarter last year.

    Same quarter last year: $5.8M; its normal quarter is $4.4M.

    See the evidence
    This period
    $13.5M (the quarter ended 31 Mar 2025)
    Normal quarter (median of 8 earlier)
    $4.4M
    Typical spread (median absolute deviation)
    $863K
    How far from its usual level
    +7.1
    Same quarter last year
    $5.8M
    History used
    3,743 days
    2023-03-31: $3.9M2023-06-30: $4.3M2023-09-30: $3.3M2023-12-31: $3.6M2024-03-31: $5.8M2024-06-30: $4.5M2024-09-30: $5.5M2024-12-31: $5.4M2025-03-31: $13.5M
    the quarter ended 31 Mar 20258 earlier quartersnormal: $4.4M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  11. 21 Feb 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  12. 21 Feb 2025Filings record

    Director or officer change

  13. 21 Mar 2024Filings record

    Changed its auditor

  14. 27 Feb 2024Financials change

    reported revenue of $284.7M for the quarter ended 31 Dec 2023, 1.3× the same quarter last year.

    Same quarter last year: $221.2M; its normal quarter is $217.4M.

    See the evidence
    This period
    $284.7M (the quarter ended 31 Dec 2023)
    Normal quarter (median of 8 earlier)
    $217.4M
    Typical spread (median absolute deviation)
    $13.5M
    How far from its usual level
    +3.1
    Same quarter last year
    $221.2M
    History used
    3,562 days
    2021-12-31: $204.0M2022-03-31: $203.9M2022-06-30: $208.3M2022-09-30: $213.7M2022-12-31: $221.2M2023-03-31: $241.4M2023-06-30: $261.5M2023-09-30: $270.9M2023-12-31: $284.7M
    the quarter ended 31 Dec 20238 earlier quartersnormal: $217.4M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  15. 14 Aug 2023Institutional holdings change

    saw 79 13F filers open a new position in the quarter ended 30 Jun 2023, 2.5× the same quarter last year.

    Same quarter last year: 31; its normal quarter is 38.5.

    See the evidence
    This period
    79 (the quarter ended 30 Jun 2023)
    Normal quarter (median of 8 earlier)
    38.5
    Typical spread (median absolute deviation)
    7.5
    How far from its usual level
    +3.6
    Same quarter last year
    31
    History used
    2,830 days
    2021-06-30: 422021-09-30: 262021-12-31: 272022-03-31: 382022-06-30: 312022-09-30: 462022-12-31: 392023-03-31: 502023-06-30: 79
    the quarter ended 30 Jun 20238 earlier quartersnormal: 38.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  16. 12 Jan 2023Short interest and volume change

    had 3.8M shares sold short in the 30 Dec 2022 report, 2.0× the same report last year.

    Same report last year: 1.9M; its normal report is 2.0M.

    See the evidence
    This period
    3.8M (the 30 Dec 2022 report)
    Normal report (median of 24 earlier)
    2.0M
    Typical spread (median absolute deviation)
    283K
    How far from its usual level
    +4.3
    Same report last year
    1.9M
    History used
    1,827 days
    2021-12-15: 1.9M2022-01-14: 1.7M2022-01-31: 1.6M2022-02-15: 1.6M2022-02-28: 1.7M2022-03-15: 1.7M2022-03-31: 1.7M2022-04-14: 1.7M2022-04-29: 1.7M2022-05-13: 1.5M2022-05-31: 1.5M2022-06-15: 1.8M2022-06-30: 2.2M2022-07-15: 2.2M2022-07-29: 2.0M2022-08-15: 2.1M2022-08-31: 2.1M2022-09-15: 2.2M2022-09-30: 2.3M2022-10-14: 2.4M2022-10-31: 2.8M2022-11-15: 3.1M2022-11-30: 3.3M2022-12-15: 3.6M2022-12-30: 3.8M
    the 30 Dec 2022 report24 earlier reportsnormal: 2.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  17. 28 Dec 2022Short interest and volume change

    had 3.6M shares sold short in the 15 Dec 2022 report, 1.9× the same report last year.

    Same report last year: 1.9M; its normal report is 1.8M.

    See the evidence
    This period
    3.6M (the 15 Dec 2022 report)
    Normal report (median of 24 earlier)
    1.8M
    Typical spread (median absolute deviation)
    237K
    How far from its usual level
    +4.9
    Same report last year
    1.9M
    History used
    1,812 days
    2021-11-30: 1.5M2021-12-15: 1.9M2022-01-14: 1.7M2022-01-31: 1.6M2022-02-15: 1.6M2022-02-28: 1.7M2022-03-15: 1.7M2022-03-31: 1.7M2022-04-14: 1.7M2022-04-29: 1.7M2022-05-13: 1.5M2022-05-31: 1.5M2022-06-15: 1.8M2022-06-30: 2.2M2022-07-15: 2.2M2022-07-29: 2.0M2022-08-15: 2.1M2022-08-31: 2.1M2022-09-15: 2.2M2022-09-30: 2.3M2022-10-14: 2.4M2022-10-31: 2.8M2022-11-15: 3.1M2022-11-30: 3.3M2022-12-15: 3.6M
    the 15 Dec 2022 report24 earlier reportsnormal: 1.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  18. 10 Dec 2022Short interest and volume change

    had 3.3M shares sold short in the 30 Nov 2022 report, 2.1× the same report last year.

    Same report last year: 1.5M; its normal report is 1.8M.

    See the evidence
    This period
    3.3M (the 30 Nov 2022 report)
    Normal report (median of 24 earlier)
    1.8M
    Typical spread (median absolute deviation)
    254K
    How far from its usual level
    +4.0
    Same report last year
    1.5M
    History used
    1,797 days
    2021-11-15: 1.5M2021-11-30: 1.5M2021-12-15: 1.9M2022-01-14: 1.7M2022-01-31: 1.6M2022-02-15: 1.6M2022-02-28: 1.7M2022-03-15: 1.7M2022-03-31: 1.7M2022-04-14: 1.7M2022-04-29: 1.7M2022-05-13: 1.5M2022-05-31: 1.5M2022-06-15: 1.8M2022-06-30: 2.2M2022-07-15: 2.2M2022-07-29: 2.0M2022-08-15: 2.1M2022-08-31: 2.1M2022-09-15: 2.2M2022-09-30: 2.3M2022-10-14: 2.4M2022-10-31: 2.8M2022-11-15: 3.1M2022-11-30: 3.3M
    the 30 Nov 2022 report24 earlier reportsnormal: 1.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  19. 26 Nov 2022Short interest and volume change

    had 3.1M shares sold short in the 15 Nov 2022 report, 2.0× the same report last year.

    Same report last year: 1.5M; its normal report is 1.8M.

    See the evidence
    This period
    3.1M (the 15 Nov 2022 report)
    Normal report (median of 24 earlier)
    1.8M
    Typical spread (median absolute deviation)
    218K
    How far from its usual level
    +4.2
    Same report last year
    1.5M
    History used
    1,782 days
    2021-10-29: 1.8M2021-11-15: 1.5M2021-11-30: 1.5M2021-12-15: 1.9M2022-01-14: 1.7M2022-01-31: 1.6M2022-02-15: 1.6M2022-02-28: 1.7M2022-03-15: 1.7M2022-03-31: 1.7M2022-04-14: 1.7M2022-04-29: 1.7M2022-05-13: 1.5M2022-05-31: 1.5M2022-06-15: 1.8M2022-06-30: 2.2M2022-07-15: 2.2M2022-07-29: 2.0M2022-08-15: 2.1M2022-08-31: 2.1M2022-09-15: 2.2M2022-09-30: 2.3M2022-10-14: 2.4M2022-10-31: 2.8M2022-11-15: 3.1M
    the 15 Nov 2022 report24 earlier reportsnormal: 1.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  20. 10 Nov 2022Short interest and volume change

    had 2.8M shares sold short in the 31 Oct 2022 report, 1.6× the same report last year.

    Same report last year: 1.8M; its normal report is 1.8M.

    See the evidence
    This period
    2.8M (the 31 Oct 2022 report)
    Normal report (median of 24 earlier)
    1.8M
    Typical spread (median absolute deviation)
    179K
    How far from its usual level
    +4.0
    Same report last year
    1.8M
    History used
    1,767 days
    2021-10-15: 1.8M2021-10-29: 1.8M2021-11-15: 1.5M2021-11-30: 1.5M2021-12-15: 1.9M2022-01-14: 1.7M2022-01-31: 1.6M2022-02-15: 1.6M2022-02-28: 1.7M2022-03-15: 1.7M2022-03-31: 1.7M2022-04-14: 1.7M2022-04-29: 1.7M2022-05-13: 1.5M2022-05-31: 1.5M2022-06-15: 1.8M2022-06-30: 2.2M2022-07-15: 2.2M2022-07-29: 2.0M2022-08-15: 2.1M2022-08-31: 2.1M2022-09-15: 2.2M2022-09-30: 2.3M2022-10-14: 2.4M2022-10-31: 2.8M
    the 31 Oct 2022 report24 earlier reportsnormal: 1.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  21. 8 Apr 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  22. 8 Apr 2022Filings record

    Director or officer change

  23. 7 Oct 2021Filings record

    Completed an acquisition or asset sale

  24. 28 Jan 2021Short interest and volume change

    had 6.1M shares sold short in the 15 Jan 2021 report, 1.5× the same report last year.

    Same report last year: 4.0M; its normal report is 3.3M.

    See the evidence
    This period
    6.1M (the 15 Jan 2021 report)
    Normal report (median of 24 earlier)
    3.3M
    Typical spread (median absolute deviation)
    516K
    How far from its usual level
    +3.6
    Same report last year
    4.0M
    History used
    1,113 days
    2020-01-15: 4.0M2020-01-31: 3.9M2020-02-14: 3.8M2020-02-28: 3.9M2020-03-13: 3.4M2020-03-31: 3.2M2020-04-15: 3.2M2020-04-30: 3.1M2020-05-15: 3.0M2020-05-29: 3.0M2020-06-15: 2.8M2020-06-30: 3.0M2020-07-15: 2.8M2020-07-31: 2.6M2020-08-14: 2.4M2020-08-31: 2.8M2020-09-15: 3.1M2020-09-30: 3.8M2020-10-15: 4.8M2020-10-30: 4.6M2020-11-13: 4.6M2020-11-30: 4.5M2020-12-15: 5.6M2020-12-31: 5.9M2021-01-15: 6.1M
    the 15 Jan 2021 report24 earlier reportsnormal: 3.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  25. 13 Nov 2020Institutional holdings record

    Capital Research Global Investors opened a $306.0M position (2020Q3 13F)

  26. 12 May 2020Financials change

    spent $10.1M on capital projects in the quarter ended 31 Mar 2020, 4.1× the same quarter last year.

    Same quarter last year: $2.5M; its normal quarter is $2.9M.

    See the evidence
    This period
    $10.1M (the quarter ended 31 Mar 2020)
    Normal quarter (median of 8 earlier)
    $2.9M
    Typical spread (median absolute deviation)
    $732K
    How far from its usual level
    +6.6
    Same quarter last year
    $2.5M
    History used
    1,917 days
    2018-03-31: $2.8M2018-06-30: $2.3M2018-09-30: $1.5M2018-12-31: $3.0M2019-03-31: $2.5M2019-06-30: $3.7M2019-09-30: $7.9M2019-12-31: $8.0M2020-03-31: $10.1M
    the quarter ended 31 Mar 20208 earlier quartersnormal: $2.9M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  27. 12 May 2020Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  28. 12 May 2020Filings record

    Director or officer change

  29. 3 Mar 2020Financials change

    spent $8.0M on capital projects in the quarter ended 31 Dec 2019, 2.6× the same quarter last year.

    Same quarter last year: $3.0M; its normal quarter is $2.9M.

    See the evidence
    This period
    $8.0M (the quarter ended 31 Dec 2019)
    Normal quarter (median of 8 earlier)
    $2.9M
    Typical spread (median absolute deviation)
    $732K
    How far from its usual level
    +4.7
    Same quarter last year
    $3.0M
    History used
    1,826 days
    2017-12-31: $5.7M2018-03-31: $2.8M2018-06-30: $2.3M2018-09-30: $1.5M2018-12-31: $3.0M2019-03-31: $2.5M2019-06-30: $3.7M2019-09-30: $7.9M2019-12-31: $8.0M
    the quarter ended 31 Dec 20198 earlier quartersnormal: $2.9M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  30. 25 Nov 2019Filings record

    Director or officer change

  31. 12 Nov 2019Financials change

    spent $7.9M on capital projects in the quarter ended 30 Sep 2019, 5.4× the same quarter last year.

    Same quarter last year: $1.5M; its normal quarter is $2.6M.

    See the evidence
    This period
    $7.9M (the quarter ended 30 Sep 2019)
    Normal quarter (median of 8 earlier)
    $2.6M
    Typical spread (median absolute deviation)
    $750K
    How far from its usual level
    +4.7
    Same quarter last year
    $1.5M
    History used
    1,734 days
    2017-09-30: $1.4M2017-12-31: $5.7M2018-03-31: $2.8M2018-06-30: $2.3M2018-09-30: $1.5M2018-12-31: $3.0M2019-03-31: $2.5M2019-06-30: $3.7M2019-09-30: $7.9M
    the quarter ended 30 Sep 20198 earlier quartersnormal: $2.6M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  32. 29 Aug 2019Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  33. 29 Aug 2019Filings record

    Director or officer change

  34. 18 Jan 2019Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  35. 18 Jan 2019Filings record

    Director or officer change

  36. 4 Sep 2018Filings record

    Completed an acquisition or asset sale

  37. 31 May 2018Insiders record

    O'Rourke Bridget (director) bought 700 shares of PEN ($109,480) (dated 30 May 2018)

  38. 20 Oct 2017Lobbying record

    PENUMBRA, INC.: lobbying engagement terminated (in-house) (dated 1 Jul 2017)

  39. 10 Jul 2017Filings record

    Completed an acquisition or asset sale

  40. 21 Apr 2017Filings record

    Director or officer change

Showing the newest 40 of 45 entries; narrow the window or the kind of data to see older ones.

Not listed: 483 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001321732
Ticker
PEN
Domain
penumbrainc.com
Employer name
Penumbra, Inc. (1 unverified)
Hq location
CA|ALAMEDA|94502 (1 unverified)
Lobbying client
penumbra
Name
Crossmed S.p.A, Penumbra Costa Rica, S.R.L, Penumbra Denmark ApS, Penumbra Europe GmbH and 12 more
Uei
QLC9LYKADGX5
Wikidata
Q104822216
Wikipedia
Penumbra (medical company)
  • DOL H-1B labor condition applications and PERM certifications816 data points1 Oct 2019 to 21 Sep 2026
  • Federal lobbying disclosures (LDA)2 records, 9 data points27 Oct 2016 to 30 Sep 2017
  • SEC Form 13F institutional holdings1 record, 405 data points30 Sep 2015 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)114 records23 Feb 2016 to 29 Oct 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)903 data points31 Dec 2012 to 14 Oct 2026
  • SEC Form 4 insider transactions386 records, 976 data points17 May 2016 to 6 Apr 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards1104 data points7 Nov 2007 to 16 Jul 2026
  • Wikipedia pageviews2144 data points8 Jan 2021 to 21 Nov 2026